Risk Assessment Key to Breast Cancer Detection and Diagnosis

International panel of experts agree appropriate lifestyle and family analysis needed to tackle breast cancer

Better risk assessment, screening, diagnosis and treatment opportunities were the focal points for an international panel of breast cancer experts gathered for the London Breast Institute’s 2nd International Symposium. A proper assessment of genetic and lifestyle factors affecting a person’s likelihood of developing breast cancer was agreed as the key to future medical approaches.

Speaking at the London Breast Institute’s 2nd annual International Symposium at the Royal Society of Medicine on 2 October 2008, renowned clinical voices discussed the latest developments in breast cancer research, detection, diagnosis and treatment.

Breast cancer risk management has become a serious concern for researchers and medical practitioners alike, with some studies suggesting the proportion of sufferers with a family history of the disease is approaching 14%. Crucial to diagnosing and receiving early treatment, assessing the risk of cancer is now a key step forward in stopping the disease in its tracks.

Professor Roland Holland, St Radboud University Nijmegen Medical Centre, the Netherlands, a leader in breast cancer risk and genetics, identified the six categories of risk and related management recommendations pinpointed by some of the world’s leaders in breast cancer care, genetics and risk assessment. “Risk assessment can lead to an earlier diagnosis, help other family members at risk and might even prevent the cancer from developing.”

“Ensuring that all women have regular and competent assessment of the family history of cancer is a high public health and clinical priority,” said Dr Robert Smith, Director of Cancer Screening, the American Cancer Society. “Many women do not have family structures where inherent risk is evident; family histories on the paternal and even maternal side are often not known by the patient.”

Revolutionary 3D imaging technology due for introduction into the UK in the coming months, was discussed as an indication of the technological developments ahead to help detect the early signs of breast cancer. Research has shown that this technology produces a more sensitive image analysis and provides significantly better tumour visibility than even standard digital mammography.

Professor Ingvar Andersson of Malmo University, Sweden said, “We believe Tomosynthesis will play an important role in the detection and diagnosis of breast cancer in the future.”

Professor Michael Baum of University College London and Chairman of the Research Board of the London Breast Institute, shared information on a multinational clinical trial of a novel system for intra-operative radiotherapy using a mobile unit that could mean an end to daily trips to a radiotherapy centre for up to six weeks – a significant reduction in treatment timeframes and an essential treatment solution for breast cancer sufferers around the world without easy access to a radiotherapy centre.

“We serve a population of women in London who have denser breast tissue and appear to be at increased risk. Forty percent of patients we diagnose with breast cancer are under 50 years old,” concluded Dr Nicholas Perry, Clinical Director of the London Breast Institute at the Princess Grace Hospital.

“By hosting this International Symposium, the London Breast Institute underlines its commitment to the importance of research and up-to-date knowledge and equipment, in constantly pursuing improved diagnostic and disease management techniques.”

29th Annual GP Forum

HCA International are proud to have given their support to the 29th Annual GP Forum which was held on Monday 14 to Friday 18 September 2009 at The Royal Society of Medicine in London.

The forum took place over five days and had a varied programme of lectures and workshops on a wide-ranging selection of clinical topics. These topics included ophthalmology, obstetric, medicine, urogenital health, travel medicines and sports medicine.

The Forum provided delegates with an opportunity to gain knowledge and network with colleagues as they enjoy the comfortable surroundings of The Royal Society of Medicine.

There was an excellent line-up of speakers, all of whom are well-known in their respective fields. For more information about this event or the speakers, please visithttp://www.rsm.ac.uk/academ/gpg100.php

Stem Cells and Breast Tissue Research

“Our continuous research programmes into breast health and treatment have particular focus on improving the clinical and aesthetic outcomes for women who have suffered from breast cancer,” says Professor Kefah Mokbel of the London Breast Institute at the Princess Grace Hospital in central London.

"We are at the early stages of developing our own contribution to robust clinical trials using stem cells to help replace tissue removed during essential surgery that may, in time, also have applications for breast enhancement.  This work will build on established techniques in use in Japan and will add to the current European trial."

Visit the London Breast Institute website

Important Information - Swine Flu H1N1(A)

We would like to reassure you that HCA International has developed contingency plans for the management of incidents such as the current SIV outbreak throughout all of its facilities and hospitals.

However if you think you have H1N1 (A) (Swine Flu) please DO NOT come into the Urgent Care Centre or hospital. Call your GP, the NHS or the National Pandemic Flu Service on the numbers provided below, for more information on symptoms and what precautions you need to take if you think you have been infected.

National Pandemic Flu Service
Phone 0800 151 3100 or visit www.pandemicflu.direct.gov.uk for advice on symptoms, online assessment form and general information on Swine Flu.

Swine Flu Information Line Phone 0800 151 3513 or visit www.nhs.uk

If you are scheduled to come into hospital

HCA usually asks patients who come in for care with colds and flu to re-schedule their treatment.
This is because treatment places a patient at increased risk if they have infections in addition to their condition.
If you have flu-like symptoms and are planning to come in for any kind of treatment (inpatient, day case or outpatient care)

• Please phone your consultant
• Then phone HCA to discuss your appointment timing

Advice for visitors

Do not visit if you have any flu-like symptoms

If you have any symptoms of influenza (e.g. cough, fever, sneezing, runny nose, sore throat), it is strongly advised that YOU DO NOT VISIT.

Influenza is caused by a virus spreading from person-to-person through droplets in the air and on surfaces.

The most effective method of preventing transmission of influenza is good hand hygiene and respiratory hygiene, so please:

Always cover your mouth and nose when you cough or sneeze using a tissue and dispose of it into a rubbish bin and then wash your hands.

Wash your hands before and after your visit with soap and water (or use alcohol gel).

Precautions HCA is taking

HCA is proud of its record of safe care.
Infection control policies and procedures are in place.
They are designed to ensure that:

• Staff are aware of infection control safe practice
• Appropriate equipment is available
• Staff know how to use it to care for you.

Precautions you can take

If you do visit for what ever reason, please observe simply hygiene rules before, during and after your visit.

Wash your hands regularly. This is an effective protective action.

Trap coughs and sneezes in tissues. Dispose of tissues in a bin.

The Princess Grace Hospital puts your safety and well-being and that of your family and visitors first and we hope to minimise the risk to everyone.

Thank you for your understanding and cooperation.